Lady Gaga just played two incredible nights at Manchester's Co-Op Live, and Senior Social News Reporter Danielle Kate Wroe was lucky enough to go to both of them ...
Even though the Nitecore costs twice as much as its competitors, it doesn’t come with a cable. The Haribo gummy bear is under ...
FOR many athletes, a winner is defined as the man or woman who walks away from competition with a medal. But for some student athlete recipients of the Pocket Rocket Foundation scholarships, winning ...
Ponntos (left) could be the key horses in the Prix de l'Abbaye The draw for the Prix de l’Arc de Triomphe has been the talk of the town but stall position is even more important for this Group 1 ...
Meet My Blata MiniBike 2.5! 🚀 This amazing pocket rocket was a Christmas gift from my parents when I was just 7, and I've cherished it for 20 years! With a powerful 39.9cc engine, it sounds ...
The Standard's journalism is supported by our readers. When you purchase through links on our site, we may earn an affiliate commission. There are some things you just can’t step beyond your front ...
Posts from this topic will be added to your daily email digest and your homepage feed. Come for the pocket-sized power, stay for the lanyard that doubles as a USB-C cable. Come for the pocket-sized ...
Manual transmissions are practically a rarity these days. Most cars either offer them as an afterthought or skip them ...
Audioengine has branched out to make its own headphone amp and DAC. It's a premium product with a dual-DAC design and wide compatibility with headphones and IEMs. Highly pocketable, the HXL is ...
All over the mainstream market today, manual transmissions are either an option or not available at all, and while there is something to be said for modern auto boxes, many of us still want to feel ...
Rocket Companies has completed all steps necessary to acquire Mr. Cooper Group for $14.2 billion, paying 51% more than the valuation announced in March, the company said Wednesday. As part of the deal ...
Oct 3 (Reuters) - Rocket Pharmaceuticals (RCKT.O), opens new tab said on Friday it has withdrawn its application for U.S. approval of its experimental gene therapy for a rare inherited blood disorder.